C O M M U N I C A T I O N S
The Cu(I)-catalyzed, stepwise variant10,11 of Huisgen’s classic
1,3-dipolar cycloaddition process15 seems to be the best example
of click chemistry reliability to date. It enabled a rapid synthesis
of a GDP-triazole library of 85 compounds, among which one potent
inhibitor of fucosyltransferases was identified. This method may
be widely applicable for the identification of high-affinity inhibitors
of other group-transfer targets that are of biological or medicinal
interest.
Acknowledgment. This research was supported by the NIH
(C.-H.W. and K.B.S.) and National Science Foundation (K.B.S.).
We thank William Web and Scripps Center for Mass Spectrometry
for valuable technical support with mass analysis, and Professor
W. W. Cleland and Dr. Thomas Tolbert for helpful suggestions on
the manuscript. Fuc-T III was generously provided by Dr. Nahid
Razi and The Consortium for Functional Glycomics (NIHGMS -
GM 62116).
Figure 2. Inhibition study of human R-1,3-fucosyltransferase VI. (A)
Double-reciprocal plot of GDP-fucose as the variable substrate and 24 as
the inhibitor (0, 0.4, 0.8, 1.2 µM). LacNAc concentration was held constant
at 0.5 mM. (B) Double-reciprocal plot of LacNAc as the variable substrate
and 24 as the inhibitor (0, 0.4, 1.0 µM). GDP-fucose was held constant at
10 µM.
Table 1. Inhibition Constants of 24 for Various Enzymes
enzyme
IC50 (µM)
K (nM)
i
Supporting Information Available: 1H and 13C NMR data of
compound 24 and its components (azide and GDP-alkyne); procedure
for the synthesis of azides and triazole compounds and measurements
of IC50 and Ki values (PDF). This material is available free of charge
R-1,3-FucT III
R-1,3-FucT V
R-1,3-FucT VI
R-1,3-GalT
â-1,4-GalT
guanylate kinase
pyruvate kinase
1.0 ( 0.2
0.9 ( 0.1
0.15 ( 0.03
N.I.
N.I.
250 ( 60
N.I.
-
270 ( 30
62 ( 3
-
-
-
-
References
(1) (a) Staudacher, E. Trends Glycosci. Glycotechnol. 1996, 8, 391-408. (b)
Sears, P.; Wong, C.-H. Cell Mol. Life Sci. 1998, 54, 223-252.
(2) Compain, P.; Martin, O. R. Bioorg. Med. Chem. 2001, 9, 3077-3092.
(3) Qian, X.; Palcic, M. M. In Carbohydrates in Chemistry and Biology; Ernst,
B., Ed.; Wiley-VCH Verlag GmbH: Weinheim, Germany, 2000; Vol. 3,
pp 293-312.
a
N.I. No Inhibition observed at 600 µM.
Steady-state kinetic evaluation of purified 24 showed that it is a
competitive inhibitor against GDP-fucose with Ki (comp) ) 62 nM
(Figure 2A, Table 1), which would make this compound the first
nanomolar and most potent inhibitor of Fuc-Ts. The inhibition
constant of 24 represents an 800-fold improvement over GDP-
alkyne (Ki ) 47 µM). Compound 24 is a noncompetitive inhibitor
against the acceptor molecule, N-acetyllactosamine (LacNAc), with
Ki (noncomp) ) 221 ( 8 nM (Figure 2B), and is a mixed-type inhibitor
against LacNAc-â-biphenyl, with Ki-slope ) 120 ( 30 nM and
Ki-intercept ) 1000 ( 400 nM.14
The inhibition property of 24 was also tested against other
glycosyltransferases and nucleotide binding enzymes (Table 1). As
is evident from the table, 24 is a potent and highly selective inhibitor
of Fuc-T VI, the enzyme from which the library was screened
against. The molecule exhibited lower inhibition properties against
other Fuc-Ts, and no inhibition was observed against two galac-
tosyltransferases. Weak inhibition was observed for guanylate
kinase, and no inhibition was observed against the catalytically
promiscuous pyruvate kinase.
(4) Mitchell, M. L.; Tian, F.; Lee, L. V.; Wong, C.-H. Angew. Chem., Int.
Ed. 2002, 41, 3041-3044.
(5) Murray, B. W.; Takayma, S.; Schultz, J.; and Wong, C.-H. Biochemistry
1996, 35, 11183-11193.
(6) Miura, Y.; Kim, S.; Etchison, J. R.; Ding, Y.; Hindsgaul, O.; and Freeze,
H. Glycoconjugate J. 1999, 16, 725-730.
(7) de Vries, T.; Palcic, M. P.; Schoenmakers, P. S.; van den Eijnden, D. H.;
and Joziasse, D. H. Glycobiology, 1997, 7, 921-927.
(8) Kolb, H. C.; Finn, M. G.; and Sharpless, K. B. Angew. Chem., Int. Ed.
2001, 40, 2004-2021.
(9) Lewis, W. G.; Green, L. G.; Grynszpan, F.; Radic, Z.; Carlier, P. R.;
Taylor, P.; Finn, M. G.; and Sharpless, K. B. Angew. Chem., Int. Ed.
2002, 41, 1053-1057.
(10) (a) Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. Angew.
Chem., Int. Ed. 2002, 41, 2596-2599. (b) Tornφe, C. W.; Christensen,
C.; Meldal, M. J. Org. Chem. 2002, 67, 3057-3064.
(11) Fazio, F.; Bryan, M. C.; Blixt, O.; Paulson, J. C.; Wong, C.-H. J. Am.
Chem. Soc. 2002, 124, 14397-14402.
(12) Mong, K.-K. T.; Lee, V. L.; Brown, J. R.; Esko, J. D.; Wong, C. H. Several
LacNAc derivatives with different aglycons were prepared and tested,
and it was found that the aglycon binding site for Fuc-T VI is hydrophobic.
(13) de Vries, T.; Knegtel, R. M. A.; Holmes, E. H.; Macher, B. A.
Glycobiology 2001, 11, 119R-128R.
(14) The inhibition patterns as displayed by FucT VI do not permit conclusive
determination of inhibitor type (mono- or bisubstrate analogue). For an
ordered mechanism, which FucT VI most likely follows,5 either mono-
or bisubstrate analogue would produce the observed competitive (versus
GDP-fucose) and noncompetitive (versus LacNAc or LacNAc-biphenyl)
patterns.
Potent inhibitors of fucosyltransferases, and glycosyltransferases
in general, have been elusive due to the aforementioned difficulties
surrounding the family of glycosyltransfer reactions. However, the
problems of weak substrate affinity and low catalytic proficiency
of the enzyme may be offset by recruiting additional binding
features, such as hydrophobic interactions in this case.
(15) Huisgen, R. In 1,3-Dipolar Cycloaddition Chemistry; Padwa, A., Ed.;
Wiley: New York, 1984; Chapter 1, pp 1-176.
JA0302836
9
J. AM. CHEM. SOC. VOL. 125, NO. 32, 2003 9589